Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Sep 30, 2014 06:06 PM ET

 Add to portfolio

$76.55 USD

-1.31 (-1.68%)

Zacks MF Rank : 5 - Strong Sell [?]         5

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Aug 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Aug 31, 2014) 23.64
Objective Health Care - Equity
Peer HL MG

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Sell 5
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 46.81
Net Assets (Mil $) 8/31/2014 313.32
%Turnover 8/31/2014 119.00

Allocation

% of Portfolio
Large Growth 33.63
Large Value 0.00
Small Growth 15.66
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 17.06
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 8/31/2014 % of Portfolio
Health 57.54
Services 22.84
Other 7.49
Technology 6.44
Industrial Cyclical 5.69

Portfolio Holdings

Top Equity Holdings
(As of 6/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.03 28.21
AMGEN INC 5.87 23.55
BIOGEN IDEC INC 5.36 21.50
CELGENE CORP 5.27 21.17
ALEXION PHARMACEUTICALS I 3.31 13.29
VERTEX PHARMACEUTICALS IN 3.30 13.23
REGENERON PHARMACEUTICALS 3.10 12.46
ILLUMINA INC 3.00 12.02
INCYTE PHARMACEUTICALS IN 1.95 7.81

Stock Holding % of Net Assets

As Of 6/30/2014
Total Issues 80
Avg. P/E 41.08
Avg. P/Book 5.91
Avg. EPS Growth 16.16
Avg. Market Value (Mil $) 28,504

Risk

3 Year 5 Year 10 Year
Beta 0.90 1.01 0.87
Alpha 21.10 9.33 8.88
R Squared 0.25 0.39 0.39
Std. Dev. 20.72 21.23 20.66
Sharpe 2.10 1.35 2.00